O'Brien TJ - Search Results

1

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.

Vivash L, Bertram KL, Malpas CB, Marotta C, Harding IH, Kolbe S, Fielding J, Clough M, Lewis SJG, Tisch S, Evans AH, O'Sullivan JD, Kimber T, Darby D, Churilov L, Law M, Hovens CM, Velakoulis D, O'Brien TJ. Vivash L, et al. BMJ Open. 2021 Dec 16;11(12):e055019. doi: 10.1136/bmjopen-2021-055019. BMJ Open. 2021. PMID: 34916328 Free PMC article.

2

Neuropsychiatric morbidity in focal epilepsy.

Adams SJ, O'Brien TJ, Lloyd J, Kilpatrick CJ, Salzberg MR, Velakoulis D. Adams SJ, et al. Br J Psychiatry. 2008 Jun;192(6):464-9. doi: 10.1192/bjp.bp.107.046664. Br J Psychiatry. 2008. PMID: 18515901

3

Morphometric abnormalities and hyperanxiety in genetically epileptic rats: a model of psychiatric comorbidity?

Bouilleret V, Hogan RE, Velakoulis D, Salzberg MR, Wang L, Egan GF, O'Brien TJ, Jones NC. Bouilleret V, et al. Neuroimage. 2009 Apr 1;45(2):267-74. doi: 10.1016/j.neuroimage.2008.12.019. Epub 2008 Dec 25. Neuroimage. 2009. PMID: 19167503

4

In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.

Dedeurwaerdere S, Gregoire MC, Vivash L, Roselt P, Binns D, Fookes C, Greguric I, Pham T, Loc'h C, Katsifis A, Hicks RJ, O'Brien TJ, Myers DE. Dedeurwaerdere S, et al. Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):958-65. doi: 10.1007/s00259-009-1066-4. Epub 2009 Feb 10. Eur J Nucl Med Mol Imaging. 2009. PMID: 19205698

5

Clinical characteristics and outcome in patients with psychogenic nonepileptic seizures.

Jones SG, O' Brien TJ, Adams SJ, Mocellin R, Kilpatrick CJ, Yerra R, Lloyd JH, Velakoulis D. Jones SG, et al. Psychosom Med. 2010 Jun;72(5):487-97. doi: 10.1097/PSY.0b013e3181d96550. Epub 2010 Apr 5. Psychosom Med. 2010. PMID: 20368472

6

Changes in hippocampal GABAA/cBZR density during limbic epileptogenesis: relationship to cell loss and mossy fibre sprouting.

Vivash L, Tostevin A, Liu DS, Dalic L, Dedeurwaerdere S, Hicks RJ, Williams DA, Myers DE, O'Brien TJ. Vivash L, et al. Neurobiol Dis. 2011 Feb;41(2):227-36. doi: 10.1016/j.nbd.2010.08.021. Epub 2010 Sep 21. Neurobiol Dis. 2011. PMID: 20816783

7

Utility and validity of a brief cognitive assessment tool in patients with epileptic and nonepileptic seizures.

Walterfang M, Choi Y, O'Brien TJ, Cordy N, Yerra R, Adams S, Velakoulis D. Walterfang M, et al. Epilepsy Behav. 2011 Jun;21(2):177-83. doi: 10.1016/j.yebeh.2011.02.025. Epub 2011 Apr 21. Epilepsy Behav. 2011. PMID: 21514241

8

Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.

Jones NC, Nguyen T, Corcoran NM, Velakoulis D, Chen T, Grundy R, O'Brien TJ, Hovens CM. Jones NC, et al. Neurobiol Dis. 2012 Mar;45(3):897-901. doi: 10.1016/j.nbd.2011.12.005. Epub 2011 Dec 11. Neurobiol Dis. 2012. PMID: 22182692

9

Psychiatric history does not predict seizure outcome following temporal lobectomy for mesial temporal sclerosis.

Adams SJ, Velakoulis D, Kaye AH, Corcoran NM, O'Brien TJ. Adams SJ, et al. Epilepsia. 2012 Oct;53(10):1700-4. doi: 10.1111/j.1528-1167.2012.03569.x. Epub 2012 Jun 27. Epilepsia. 2012. PMID: 22738237 Free article.

10

18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.

Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O'Brien TJ. Vivash L, et al. J Nucl Med. 2013 Aug;54(8):1270-7. doi: 10.2967/jnumed.112.107359. Epub 2013 Jul 15. J Nucl Med. 2013. PMID: 23857513 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

914 results

Search Page